- Home
- ELTX vs BANX Comparison
ELTX vs BANX Comparison
Compare ELTX & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELTX | BANX |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 149.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ELTX | BANX |
|---|---|---|
| Price | $8.36 | $22.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 108.0K | 23.4K |
| Earning Date | 11-13-2025 | 06-17-2025 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.35 |
| Revenue | N/A | ★ $29,467,794.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.88 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $4.60 | $17.99 |
| 52 Week High | $12.62 | $21.67 |
Technical Indicators
Market Signals| Indicator | ELTX | BANX |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 57.49 |
| Support Level | $7.90 | $21.85 |
| Resistance Level | $8.78 | $22.50 |
| Average True Range (ATR) | 0.65 | 0.34 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 38.68 | 75.53 |
Price Performance
Historical ComparisonAbout ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.